News & Events
In a collaboration facilitated by Imperial Consultants, Professor Simon Taylor-Robinson from the Department of Medicine joined presenters Julia Bradbury, Phil Tufnell and Dr Phil Hammond, along with a team of experts and NHS volunteers, in screening almost four hundred people in Manchester, the most people ever to be screened in one place in Britain.
Screening for Type 2 diabetes, cardiovascular disease and liver disease
In addition to tests for Type 2 diabetes and cardiovascular disease, the “Long Live Britain” screening offered Fibroscans, a non-invasive method of quantifying hepatic fibrosis, to patients who showed an increased risk of liver disease. These were interpreted by Professor Taylor-Robinson, who referred patients on for further tests if necessary, including ultrasounds to obtain a more accurate picture of the fat levels in the liver.
‘Largely preventable’
Liver disease has risen by 450% in the past 30 years, with the vast majority of an estimated two million sufferers unaware that they have the disease. Together with Type 2 diabetes and cardiovascular disease, these conditions collectively kill 200,000 people per year.
Prof. Taylor-Robinson comments:
“Unless diagnosed early, liver disease can severely affect quality of life and lead to premature death. The death statistics are shocking given that all three of the diseases addressed in this programme are largely preventable. It is vital that we try and improve awareness and understanding of these conditions among the general public”.
Share post:
Latest news, insights and events

Experts issue weather warning for Britain’s electricity grid
Britain’s ever-changing weather could put its landmark net zero climate target at risk and become a threat to the power grid’s security unless policymakers take action. Independent report for Drax Electric Insights. read more

FREE Congenital Anomalies webinar – ON DEMAND
Register to see the second in our series of four, educational webinars exploring Fetal Medicine. We will explore the common (and less common) structural, chromosomal and genetic congenital abnormalities. Delivered by Imperial’s Professor Christoph Lees, and supported by GE HealthCare. read more

COVID research news shared with international community
The Imperial Global Science Policy Forum (IGSPF), attended by 300 delegates from global universities, Embassies, and industry focused on Imperial's role in the international response to the COVID-19 pandemic. read more